academic article

• High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL..  SLAS Discovery.  23:732-741. 2018
• ----Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia..  Oncotarget.  :-. 2016
• FRET detection of lymphocyte function-associated antigen-1 conformational extension..  Molecular biology of the cell.  26:43-54. 2015
• Relationship of light scatter change and cdc42-regulated actin status..  Cytometry. Part B, Clinical cytometry.  :-. 2015
• The evaluation of thioridazine as a hematopoietic progenitor cell mobilizing agent in healthy human subjects..  Journal of clinical pharmacology.  :-. 2014
• Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization..  BMC immunology.  15:-. 2014
• Characterization of a Cdc42 GTPase Inhibitor and its Use as a Molecular Probe..  The Journal of biological chemistry.  :8531. 2013
• Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. 2013
• Aspects of VLA-4 and LFA-1 regulation that may contribute to rolling and firm adhesion..  Frontiers in immunology.  3:-. 2012
• Overview: assays for studying integrin-dependent cell adhesion..  Methods in molecular biology (Clifton, N.J.).  757:3-14. 2012
• A miniature Couette to generate shear for flow cytometry: studying real-time modulation of intracellular calcium in monocytic cells..  Cytometry. Part A : the journal of the International Society for Analytical Cytology.  79:233-240. 2011
• Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists..  The Journal of biological chemistry.  286:5455-5463. 2011
• Drug Repurposing from an Academic Perspective..  Drug discovery today. Therapeutic strategies.  8:61-69. 2011
• Drug Repurposing from an Academic Perspective..  Drug discovery today. Therapeutic strategies.  8:61-69. 2011
• Drug Repurposing from an Academic Perspective..  Drug discovery today. Therapeutic strategies.  8:61-69. 2011
• Is prolonged stem cell mobilization detrimental for hematopoiesis?.  Medical hypotheses.  77:1111-1113. 2011
• Nitric oxide/cGMP pathway signaling actively down-regulates ?4?1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion..  BMC immunology.  12:-. 2011
• Real-time analysis of the inside-out regulation of lymphocyte function-associated antigen-1 revealed similarities to and differences from very late antigen-4..  The Journal of biological chemistry.  286:20375-20386. 2011
• Real-time partitioning of octadecyl rhodamine B into bead-supported lipid bilayer membranes revealing quantitative differences in saturable binding sites in DOPC and 1:1:1 DOPC/SM/cholesterol membranes. 2010
• Conformational mAb as a tool for integrin ligand discovery..  Assay and drug development technologies.  7:507-515. 2009
• Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation..  The Journal of biological chemistry.  284:14337-14346. 2009
• Dissociation of I domain and global conformational changes in LFA-1: refinement of small molecule-I domain structure-activity relationships..  Biochemistry.  44:4322-4331. 2005
• Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents. "Inside-out" signaling is independent of and additive to reduction-regulated integrin activation..  The Journal of biological chemistry.  279:32435-32443. 2004
• Alpha4beta1 integrin affinity changes govern cell adhesion. 2003
• FRET detection of cellular alpha4-integrin conformational activation..  Biophysical journal.  85:3951-3962. 2003